Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. Oral Oncol. 2015 Nov; 51(11):1011-1019.
View in:
PubMed
subject areas
Biomarkers, Tumor
Chromatography, Liquid
Epithelium
Humans
Mass Spectrometry
Mouth
Mouth Neoplasms
Proteomics
authors with profiles
Mark Lingen